Oxaliplatin: A review of preclinical and clinical studies
Open Access
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (10) , 1053-1071
- https://doi.org/10.1023/a:1008213732429
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)European Journal Of Cancer, 1998
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancerEuropean Journal Of Cancer, 1997
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996
- Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rateEuropean Journal Of Cancer, 1993
- Preliminary phase II trial of oxaliplatin (L-OHP) in malignant astrocytomasEuropean Journal Of Cancer, 1993
- Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidinesEuropean Journal Of Cancer, 1993
- Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexesChemico-Biological Interactions, 1989
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNAChemico-Biological Interactions, 1980
- New platinum complexes with anti-tumour activityChemico-Biological Interactions, 1972